Drug development links

E-mail relevant links to sg@mva.org

> IFPMA Clinical Trials Portal - provided by the The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), on behalf of its member companies and associations. The portal has been designed as a single entry allowing you to search for comprehensive information on on-going clinical trials (registry) or results of completed trials (database) conducted by the innovative pharmaceutical industry.

> Association for Configuration and Data Management - provides educational and training, emerges concepts and standards, and efficient methods and techniques to help foster tested and proven best practices and patterns in a universe of people, process, and technology performance influences.

> Danish Medicines Agency - is an agency under the Ministry of the Interior and Health, that administers the legislation on medicinal products, reimbursement on medicinal products, pharmacies, medical devices and euphoriant substances.

> Danish Society of Good Clinical Practice

> EC Directive for Clinical Trials - laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products.

> European Medical Technology Industry Association (Eucomed) - represents the interests of the majority of the non-pharmaceutical European medical technology industry.

> Medicoindustrien - is the industry organisation of companies in Denmark which develop, manufacture, sell or otherwise take an interest in CE-marked medical devices. Medicoindustrien‘s object is to promote the commercial and political interests of its member companies.

> Swedish Medical Products Agency - is the Swedish national authority responsible for regulation and surveillance of the development, manufacturing and sale of drugs and other medical products. Their task is to ensure that both the individual patient and healthcare professionals have access to safe and effective products and that these are used in a rational and cost-effective manner.

> New Safe Medicines Faster (NSMF) - an initiative aimed at improving drug development and approval in Europe by cooperation between public and private institutions.